Recurrent ovarian carcinoma
Clinical trials for Recurrent ovarian carcinoma explained in plain language.
Never miss a new study
Get alerted when new Recurrent ovarian carcinoma trials appear
Sign up with your email to follow new studies for Recurrent ovarian carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a Two-Drug combo outsmart resistant breast and ovarian cancers?
Disease control Stopped earlyResearchers are testing whether combining ribociclib and belinostat can help people with metastatic triple-negative breast cancer or recurrent ovarian cancer. The trial starts by finding the safest dose of the drug pair, then expands to see how well it works in breast cancer pati…
Matched conditions: RECURRENT OVARIAN CARCINOMA
Phase 1 • Sponsor: University of Utah • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Cancer drug combo tested for rare gene mutation – but trial stopped early
Disease control Stopped earlyThis study tested two drugs, niraparib and bevacizumab, alone or together, in people with recurrent endometrial or ovarian cancer that has a specific gene change called ARID1A. The goal was to see if the drugs could shrink tumors. However, the trial was stopped early after enroll…
Matched conditions: RECURRENT OVARIAN CARCINOMA
Phase 2 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Measles virus takes on ovarian cancer in early trial
Disease control Stopped earlyThis phase 2 trial tested a genetically modified measles virus (MV-NIS) against standard chemotherapy in 17 women with ovarian, fallopian, or peritoneal cancer that no longer responded to platinum drugs. The virus was designed to infect and kill cancer cells while leaving healthy…
Matched conditions: RECURRENT OVARIAN CARCINOMA
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC